Incidence of bradycardia with the use of remdesivir for coronavirus disease of 2019 and risk factor analysis
Remdesivir-associated bradycardia is common. Baseline HR was identified as an independent risk factor for bradycardia in hospitalized patients being treated with remdesivir for COVID-19.
Authors
- Megan Phelps (ORCID: https://orcid.org/0000-0002-4673-2392)
- Anthony T. Gerlach (ORCID: https://orcid.org/0000-0001-5631-4218)
- Samantha Steele
- Jessica L. Elefritz (ORCID: https://orcid.org/0000-0001-5690-471X)
- Heena H Sadaqat
Institutions
- The Ohio State University Wexner Medical Center (US)
- The Ohio State University (US)
Publication Details
- Journal
- International Journal of Critical Illness and Injury Science
- Published
- 2024-10-01
- DOI
- https://doi.org/10.4103/ijciis.ijciis_57_24
- Citations
- 1
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.39